Abstract
Original language | English |
---|---|
Article number | e62997 |
Journal | eLife |
Volume | 10 |
DOIs | |
Publication status | Published - 2021 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: eLife, Vol. 10, e62997, 2021.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Genetic surveillance in the greater mekong subregion and south asia to support malaria control and elimination
AU - Jacob, Christopher G.
AU - Thuy-Nhien, Nguyen
AU - Mayxay, Mayfong
AU - Maude, Richard J.
AU - Quang, Huynh Hong
AU - Hongvanthong, Bouasy
AU - Vanisaveth, Viengxay
AU - Duc, Thang Ngo
AU - Rekol, Huy
AU - van der Pluijm, Rob
AU - von Seidlein, Lorenz
AU - Fairhurst, Rick
AU - Nosten, François
AU - Hossain, Md Amir
AU - Park, Naomi
AU - Goodwin, Scott
AU - Ringwald, Pascal
AU - Chindavongsa, Keobouphaphone
AU - Newton, Paul
AU - Ashley, Elizabeth
AU - Phalivong, Sonexay
AU - Maude, Rapeephan
AU - Leang, Rithea
AU - Huch, Cheah
AU - Dong, Le Thanh
AU - Nguyen, Kim-Tuyen
AU - Nhat, Tran Minh
AU - Hien, Tran Tinh
AU - Nguyen, Hoa
AU - Zdrojewski, Nicole
AU - Canavati, Sara
AU - Sayeed, Abdullah Abu
AU - Uddin, Didar
AU - Buckee, Caroline
AU - Fanello, Caterina I.
AU - Onyamboko, Marie
AU - Peto, Thomas
AU - Tripura, Rupam
AU - Amaratunga, Chanaki
AU - Thu, Aung Myint
AU - Delmas, Gilles
AU - Landier, Jordi
AU - Parker, Daniel M.
AU - Chau, Nguyen Hoang
AU - Lek, Dysoley
AU - Suon, Seila
AU - Callery, James
AU - Jittamala, Podjanee
AU - Hanboonkunupakarn, Borimas
AU - Pukrittayakamee, Sasithon
AU - Phyo, Aung Pyae
AU - Smithuis, Frank
AU - Lin, Khin
AU - Thant, Myo
AU - Hlaing, Tin Maung
AU - Satpathi, Parthasarathi
AU - Satpathi, Sanghamitra
AU - Behera, Prativa K.
AU - Tripura, Amar
AU - Baidya, Subrata
AU - Valecha, Neena
AU - Anvikar, Anupkumar R.
AU - Islam, Akhter Ul
AU - Faiz, Abul
AU - Kunasol, Chanon
AU - Drury, Eleanor
AU - Kekre, Mihir
AU - Ali, Mozam
AU - Love, Katie
AU - Rajatileka, Shavanthi
AU - Jeffreys, Anna E.
AU - Rowlands, Kate
AU - Hubbart, Christina S.
AU - Dhorda, Mehul
AU - Vongpromek, Ranitha
AU - Kotanan, Namfon
AU - Wongnak, Phrutsamon
AU - Garcia, Jacob Almagro
AU - Pearson, Richard D.
AU - Ariani, Cristina V.
AU - Chookajorn, Thanat
AU - Malangone, Cinzia
AU - Nguyen, T.
AU - Stalker, Jim
AU - Jeffery, Ben
AU - Keatley, Jonathan
AU - Johnson, Kimberly J.
AU - Muddyman, Dawn
AU - Chan, Xin Hui S.
AU - Sillitoe, John
AU - Amato, Roberto
AU - Simpson, Victoria
AU - Gonçalves, Sonia
AU - Rockett, Kirk
AU - Day, Nicholas P.
AU - Dondorp, Arjen M.
AU - Kwiatkowski, Dominic P.
AU - Miotto, Olivo
N1 - Funding Information: We are grateful all patients and health workers who participated in sample collections. This study used data from the MalariaGEN Pf3k Project and Plasmodium falciparum Community Project. We thank the staff of Wellcome Sanger Institute Sample Logistics, Sequencing, and Informatics facilities for their contribution; in particular, we are grateful to the Wellcome Sanger Institute DNA Pipelines Informatics team for supporting the development of the methods used in this work. We thank the many collaborators who contributed to the GenRe-Mekong Project, and especially: Pannapat Masingboon, Narisa Thongmee, Zoë Doran, Salwaluk Panapipat, Ipsita Sinha, Rapeephan Maude, Vilasinee Yuwaree, Tran Minh Nhat, Hoang Hai Phuc, Ro Mah Huan, Nguyen Minh Nhat, Tran Van Don. PR is a staff member of the World Health Organization; PR alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions, policy or views of the World Health Organization. This work was supported, in whole or in part, by the Bill and Melinda Gates Foundation [OPP11188166, OPP1204268]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. Funding Information: Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community. Funding: The GenRe-Mekong project is funded by the Bill and Melinda Gates Foundation (OPP11188166, OPP1204268). Genotyping and sequencing were funded by the Wellcome Trust (098051, 206194, 203141, 090770, 204911, 106698/B/14/Z) and Medical Research Council (G0600718). A proportion of samples were collected with the support of the UK Department for International Development (201900, M006212), and Intramural Research Program of the National Institute of Allergy and Infectious Diseases. Publisher Copyright: © 2021, eLife Sciences Publications Ltd. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community.
AB - Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS) that enables NMCPs to implement large-scale surveillance projects by integrating simple sample collection procedures in routine public health procedures. Methods: Samples from symptomatic patients are processed by SpotMalaria, a high-throughput system that produces a comprehensive set of genotypes comprising several drug resistance markers, species markers and a genomic barcode. GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions used to map prevalence of resistance to multiple drugs. Results: GenRe-Mekong has worked with NMCPs and research projects in eight countries, processing 9623 samples from clinical cases. Monitoring resistance markers has been valuable for tracking the rapid spread of parasites resistant to the dihydroartemisinin-piperaquine combination therapy. In Vietnam and Laos, GenRe-Mekong data have provided novel knowledge about the spread of these resistant strains into previously unaffected provinces, informing decision-making by NMCPs. Conclusions: GenRe-Mekong provides detailed knowledge about drug resistance at a local level, and facilitates data sharing at a regional level, enabling cross-border resistance monitoring and providing the public health community with valuable insights. The project provides a rich open data resource to benefit the entire malaria community.
UR - http://www.scopus.com/inward/record.url?scp=85113798922&partnerID=8YFLogxK
U2 - https://doi.org/10.7554/ELIFE.62997
DO - https://doi.org/10.7554/ELIFE.62997
M3 - Article
C2 - 34372970
SN - 2050-084X
VL - 10
JO - eLife
JF - eLife
M1 - e62997
ER -